ArticleDrug safety2020
Prospective Evaluation of Adverse Event Recognition Systems in Twitter: Results from the Web-RADR Project.
Article in Drug safety, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Detecting Adverse Drug Events in Social Media: A Brief Literature Review.SN computer science · 2026Article
- Opinion Mining of Erowid's Experience Reports on LSD and Psilocybin-Containing Mushrooms.Drug safety · 2025Article
- Pharmacovigilance in the digital age: gaining insight from social media data.Experimental biology and medicine (Maywood, N.J.) · 2025Review
- Artificial intelligence: revolutionizing cardiology with large language models.European heart journal · 2024Article
- An Assessment of Mentions of Adverse Drug Events on Social Media With Natural Language Processing: Model Development and Analysis.JMIR medical informatics · 2022Article
- Biases in using social media data for public health surveillance: A scoping review.International journal of medical informatics · 2022Article
- Intelligent Telehealth in Pharmacovigilance: A Future Perspective.Drug safety · 2022Review
- Automated Drug Coding Using Artificial Intelligence: An Evaluation of WHODrug Koda on Adverse Event Reports.Drug safety · 2022Article
- Mild Adverse Events of Sputnik V Vaccine in Russia: Social Media Content Analysis of Telegram via Deep Learning.Journal of medical Internet research · 2021Article
- Identifying Actionability as a Key Factor for the Adoption of 'Intelligent' Systems for Drug Safety: Lessons Learned from a User-Centred Design Approach.Drug safety · 2021Article
- Incorporating Unstructured Patient Narratives and Health Insurance Claims Data in Pharmacovigilance: Natural Language Processing Analysis of Patient-Generated Texts About Systemic Lupus Erythematosus.JMIR public health and surveillance · 2021Article
- Pharmacovigilance and the digital world in Italy: presentation of the results of a national survey.Therapeutic advances in drug safety · 2021Article
- Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR.Drug safety · 2019Article
- The DynAIRx Project Protocol: Artificial Intelligence for dynamic prescribing optimisation and care integration in multimorbidity.Journal of multimorbidity and comorbidityArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introductionA large number of studies on systems to detect and sometimes normalize adverse events (AEs) in social media have been published, but evidence of their practical utility is scarce. This raises the question of the transferability of such systems to new settings.
objectivesThe aims of this study were to develop an AE recognition system, prospectively evaluate its performance on an external benchmark dataset and identify potential factors influencing the transferability of AE recognition systems.
methodsA pipeline based on dictionary lookups and logistic regression classifiers was developed using a proprietary dataset of 196,533 Tweets manually annotated for AE relations and prospectively evaluated the system on the publicly available WEB-RADR reference dataset, exploring different aspects affecting transferability.
resultsOur system achieved 0.53 precision, 0.52 recall and 0.52 F1-score on the development test set; however, when applied to the WEB-RADR reference dataset, system performance dropped to 0.38 precision, 0.20 recall and 0.26 F1-score. Similarly, a previously published method aiming at automatically detecting adverse event posts reported 0.5 precision, 0.92 recall and 0.65 F1-score on thus another dataset, while performance on the WEB-RADR reference dataset was reduced to 0.37 precision, 0.63 recall and 0.46 F1-score. We identified four potential factors leading to poor transferability: overfitting, selection bias, label bias and prevalence.
conclusionWe warn the community about a potentially large discrepancy between the expected performance of automated AE recognition systems based on published results and the actual observed performance on independent data. This study highlights the difficulty of implementing an all-purpose system for automatic adverse event recognition in Twitter, which could explain the lack of such systems in practical pharmacovigilance settings. Our recommendation is to use benchmark independent datasets, such as the WEB-RADR reference, to investigate the transferability of the adverse event recognition systems and ultimately enforce rigorous comparisons across studies on the task.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.